ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2026

Abstract Number: 1493

Barriers and Facilitators of Medication Adherence in Childhood-Onset Systemic Lupus Erythematosus: A Qualitative Study

Rebecca Sadun1, Laura Mkumba2, Bryce Reeve3, Lisa Carnago4, Kaveh Ardalan3, Laura Schanberg5, Rachel Randell6, Gary Maslow7, Kai Sun1 and Megan Clowse8

Affiliations: 1Department of Medicine, Duke University School of Medicine, Durham, NC, 2Department of Population Health, Duke University, Durham, 3Duke University School of Medicine, Durham, NC, 4Duke University, Hillsborough, NC, 5Duke University Medical Center, DURHAM, NC, 6Duke University, Durham, NC, 7Duke University Medical Center, Durham, 8Duke University, Chapel Hill, NC

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2026

Keywords: health behaviors, Pediatric rheumatology, Qualitative Research, Systemic lupus erythematosus (SLE)

Session Information

Date: Monday, November 9, 2026

Title: (1491-1526) Pediatric Rheumatology - Clinical Poster B

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Up to 75% of children and adolescents with childhood-onset SLE (cSLE) struggle to take medications as prescribed. The COM-B Model of Medication Non-Adherence has been a useful model for examining the factors that can interfere with adult SLE patients’ capability, opportunity, and motivation to take SLE medications (the behavior); however, studies have not used this model to analyze the reasons that cSLE patients struggle with adherence. This study applied the COM-B model to examine the adherence barriers and facilitators described by pediatric cSLE patients.

 

Methods: cSLE patients ages 11-23 years receiving care at a single academic medical center were invited to participate in semi-structured interviews as part of a larger patient-reported measure development study. Interviews were audio-recorded, transcribed, and summarized. An interim inductive qualitative analysis was performed to identify emerging themes. Interview summaries were reviewed by two analysts, and consensus was reached regarding thematic findings.

Results: Eleven cSLE patients participated. Participants were 12-20 years of age (median 17 years); 10/11 (91%) were female, 5 (45%) Hispanic, 4 (36%) Black, 3 (27%) White, with race not reported by 4 (36%). Participants described both obstacles to adherence and tools that have been helpful in their efforts to take their lupus medications.

Capability. Barriers: The most discussed challenge was “remembering” to take medications, with specific difficulties including rushing to leave the house/dorm in the morning, remembering at times when they didn’t have immediate access to their pills, and falling asleep before their evening dose. Facilitators: The vast majority described utilizing pill organizers and phone alarms as reminders. One participant expressed she preferred smaller compartments over a traditional pill box because they allow her to take each day’s pills with her. Two patients shared that they place their medications in prominent locations (e.g. dresser and mini-fridge) to serve as visual reminders.

Opportunity. Barriers: One participant described missing three days of medication while waiting on refills, and another explained that she was off her medication for three months due to insurance challenges. Facilitators: Multiple patients discussed friends and family being powerful resources in the effort to take daily medications; one participant’s mother video called her each morning to remind and watch her take her medications.

Motivation. Barriers: Factors negatively impacting motivation included bad taste, difficulty swallowing pills, side effects like nausea, and not feeling worse after missing doses. Participants also discussed the burden of chronic medications, stating: “It’s hard thinking of having to take medication every day.” Facilitator: One participant identified positive motivation as a tool for taking medication, describing how he coaches himself to remember that “it will help me feel better.”

 

Conclusion: Children, adolescents, and young adults with SLE each named multiple barriers to taking daily lupus medications. In addition, they independently identified tools, strategies, and people able to help them achieve medication adherence.


Disclosures: R. Sadun: None; L. Mkumba: None; B. Reeve: Daiichi Sankyo, 12,, Vertex Pharmaceuticals, 12,; L. Carnago: GLG, 12,, RheumNow.com, 12,; K. Ardalan: Cabaletta Bio, 12,, 12, , Cartesian Therapeutics, 12,, SingHealth, 12,; L. Schanberg: AbbVie/Abbott, 12,, Amgen, 12,, Bristol-Myers Squibb(BMS), 12,, Fresenius Kabi, 12,, NIAMS, 12,, Patient Centered Outcomes Research Institute, 12,, Pfizer, 12,, Sanofi, 12,; R. Randell: biogen, 12,; G. Maslow: None; K. Sun: Garner Health, 12,; M. Clowse: AstraZeneca, 12,, GlaxoSmithKlein(GSK), 12,, Immunovant, 12,, MotherToBaby, 12,, UCB, 12,.

To cite this abstract in AMA style:

Sadun R, Mkumba L, Reeve B, Carnago L, Ardalan K, Schanberg L, Randell R, Maslow G, Sun K, Clowse M. Barriers and Facilitators of Medication Adherence in Childhood-Onset Systemic Lupus Erythematosus: A Qualitative Study [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/barriers-and-facilitators-of-medication-adherence-in-childhood-onset-systemic-lupus-erythematosus-a-qualitative-study/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/barriers-and-facilitators-of-medication-adherence-in-childhood-onset-systemic-lupus-erythematosus-a-qualitative-study/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology